Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression

医学 视神经病变 外科减压 外科 减压 眼科 视神经
作者
Nicola Currò,Claudio Guastella,Giacinta Pirola,Barbara Calonghi,Alessandra Bottari de Castello,Maria Chiara Fazio,Sabina di Benedetto,Valeria Minorini,Marco Daga,Andrea Contarino,Ilaria Muller,Maura Arosio,Francesco Viola,Lorenzo Pignataro,Mario Salvi
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:33 (6): 743-751 被引量:3
标识
DOI:10.1089/thy.2022.0564
摘要

Background: Current guidelines suggest high-dose steroids as first-line treatment for dysthyroid optic neuropathy (DON). When steroids fail, decompressive surgery is mandatory. Methods: We conducted a single-center, retrospective cohort study in a tertiary care combined Thyroid-Eye clinic in Milan, Italy. We studied 88 orbits of 56 patients that were submitted to surgical orbital decompression to treat DON from 2005 to 2020. Of these, 33 orbits (37.5%) underwent surgery as first-line treatment for DON whereas the other 55 (62.5%) were decompressed after being unresponsive to very high-dose steroids. Previous orbital surgery, concurrent neurological or ophthalmologic diseases, or incomplete follow-up were considered as exclusion criteria from this study. Surgery was considered successful if no further decompression was needed to preserve vision. Pinhole best corrected visual acuity (p-BCVA), color sensitivity, automated visual field, pupil reflexes, optic disk and fundus appearance, exophtalmometry, and ocular motility were studied before and after surgery (1 week, 1, 3, 6, and 12 months). Activity of Graves' Orbitopathy (GO) was graded using a clinical activity score (CAS). Results: Surgery was successful in 77 orbits (87.5%). The remaining 11 orbits (12.5%) needed further surgery to treat DON definitively. All parameters of visual function improved significantly at follow-up and GO inactivated (CAS <3) within 1 month. At 3 months, all 77 responding orbits had p-BCVA >0.63 whereas all of the 11 non-responding orbits had p-BCVA ≤0.63. Visual field parameters and color sensitivity were not associated with response to surgery. High-dose steroid treatment before surgery was associated with a better response rate (96% vs. 73%; p = 0.004). Balanced decompression was associated with a higher response rate compared with medial wall decompression (96% vs. 80%; p = 0.04). A significant inverse correlation was observed between final p-BCVA and the patient's age (r = -0.42; p = 0.0003). Conclusions: Surgical decompression was found to be a very effective treatment for DON. In this study, all clinical parameters improved after surgery and further intervention was rarely needed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
好好学习发布了新的文献求助10
2秒前
2秒前
silence完成签到,获得积分10
2秒前
2秒前
zzzz应助自然友菱采纳,获得10
3秒前
3秒前
李晶晶完成签到,获得积分10
3秒前
小厂长QwQ完成签到,获得积分10
4秒前
啊哈发布了新的文献求助10
4秒前
喜悦寄风发布了新的文献求助10
4秒前
请亏我全完成签到,获得积分10
4秒前
烟花应助科研小小小白采纳,获得10
4秒前
zheng发布了新的文献求助10
4秒前
Orange应助美丽凛采纳,获得10
4秒前
热烈的马完成签到,获得积分20
5秒前
YJT发布了新的文献求助10
5秒前
5秒前
zjh33完成签到,获得积分10
6秒前
6秒前
科研通AI6.2应助岄岒yq采纳,获得10
7秒前
檀熹发布了新的文献求助10
7秒前
7秒前
激昂的香寒完成签到,获得积分10
7秒前
妍妍发布了新的文献求助10
7秒前
8秒前
哈哈哈哈完成签到,获得积分10
8秒前
yyp011218发布了新的文献求助10
8秒前
Lucas应助沉静的长颈鹿采纳,获得10
8秒前
霸气千易完成签到,获得积分10
8秒前
进击的小羊完成签到,获得积分10
8秒前
9秒前
可爱的函函应助BE采纳,获得10
9秒前
ax发布了新的文献求助20
9秒前
orixero应助椰椰耶耶采纳,获得10
9秒前
10秒前
请亏我全发布了新的文献求助10
10秒前
羞涩的太阳完成签到,获得积分20
10秒前
abc发布了新的文献求助10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
Resiliency Scale for Adolescents--Chinese Version 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7326860
求助须知:如何正确求助?哪些是违规求助? 8941802
关于积分的说明 18963434
捐赠科研通 6982934
什么是DOI,文献DOI怎么找? 3215933
关于科研通互助平台的介绍 2382903
邀请新用户注册赠送积分活动 2195296